Skip navigation

maximizing solubility. boosting bioavailibility


The Experts

Opportunities to join one of the world's leading teams

News

Technologies

 

Conventional Formulation Technologies

The Classical Complement to Phares' Proprietary Formulation Technologies

In addition to the established SupraVail® family of formulation strategies, Phares offers a range of conventional compounding technologies for poorly soluble actives.

  • Suspension / Nanosuspension (Oral)
  • Co-solvent Systems (Oral, Parenteral)
  • Cyclodextrins (Oral, Parenteral, Topical)
  • Oily liquids (Oral, Parenteral, Topical)
  • Emulsions (Oral, Parenteral, Topical)
  • Microemulsions (Oral, Topical)
  • Mixed micelles (Parenteral)
  • Coprecipitates / Solid Dispersions (Oral)
  • Creams, Ointments, Gels, Lotions and Sprays (Topical)

Tap into the formulation expertise of Phares developed specifically for poorly soluble actives!

Phares works together with its clients to choose the right formulation for the right phase of development. Sometimes one certain formulation strategy is more advantageous to obtain initial preclinical results, while another formulation may be recommendable for clinical development.

For more information, click here to download the Conventional Formulation Technologies Brochure.

 
 

Back to top